vs
ALBANY INTERNATIONAL CORP（AIN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是ALBANY INTERNATIONAL CORP的1.9倍（$622.0M vs $321.2M），Royalty Pharma plc净利率更高（34.4% vs 4.3%，领先30.1%），ALBANY INTERNATIONAL CORP同比增速更快（12.0% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.2%）
奥尔巴尼国际是全球先进材料与工业技术企业，下设两大核心业务板块：为造纸等工业生产提供定制工程织物的机械织物部门，以及为航空航天、国防领域研发高性能复合材料部件的工程复合材料部门，业务覆盖全球多个区域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AIN vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$321.2M
营收增速更快
AIN
高出7.2%
4.8%
净利率更高
RPRX
高出30.1%
4.3%
两年增速更快
RPRX
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.2M | $622.0M |
| 净利润 | $13.9M | $214.2M |
| 毛利率 | 31.1% | — |
| 营业利润率 | 9.3% | 62.4% |
| 净利率 | 4.3% | 34.4% |
| 营收同比 | 12.0% | 4.8% |
| 净利润同比 | -21.5% | 2.9% |
| 每股收益（稀释后） | $0.56 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AINRPRX
| Q4 25 | $321.2M | $622.0M | ||
| Q3 25 | $261.4M | $609.3M | ||
| Q2 25 | $311.4M | $578.7M | ||
| Q1 25 | $288.8M | $568.2M | ||
| Q4 24 | $286.9M | $593.6M | ||
| Q3 24 | $298.4M | $564.7M | ||
| Q2 24 | $332.0M | $537.3M | ||
| Q1 24 | $313.3M | $568.0M |
净利润AINRPRX
| Q4 25 | $13.9M | $214.2M | ||
| Q3 25 | $-97.8M | $288.2M | ||
| Q2 25 | $9.2M | $30.2M | ||
| Q1 25 | $17.4M | $238.3M | ||
| Q4 24 | $17.7M | $208.2M | ||
| Q3 24 | $18.0M | $544.0M | ||
| Q2 24 | $24.6M | $102.0M | ||
| Q1 24 | $27.3M | $4.8M |
毛利率AINRPRX
| Q4 25 | 31.1% | — | ||
| Q3 25 | -19.1% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 33.4% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | 34.7% | — |
营业利润率AINRPRX
| Q4 25 | 9.3% | 62.4% | ||
| Q3 25 | -44.6% | 70.1% | ||
| Q2 25 | 7.2% | 36.3% | ||
| Q1 25 | 9.8% | 94.0% | ||
| Q4 24 | 8.5% | 60.9% | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | 12.9% | 50.2% | ||
| Q1 24 | 12.4% | -13.0% |
净利率AINRPRX
| Q4 25 | 4.3% | 34.4% | ||
| Q3 25 | -37.4% | 47.3% | ||
| Q2 25 | 2.9% | 5.2% | ||
| Q1 25 | 6.0% | 41.9% | ||
| Q4 24 | 6.2% | 35.1% | ||
| Q3 24 | 6.0% | 96.3% | ||
| Q2 24 | 7.4% | 19.0% | ||
| Q1 24 | 8.7% | 0.8% |
每股收益（稀释后）AINRPRX
| Q4 25 | $0.56 | $0.49 | ||
| Q3 25 | $-3.37 | $0.67 | ||
| Q2 25 | $0.31 | $0.07 | ||
| Q1 25 | $0.56 | $0.55 | ||
| Q4 24 | $0.57 | $0.46 | ||
| Q3 24 | $0.57 | $1.21 | ||
| Q2 24 | $0.79 | $0.23 | ||
| Q1 24 | $0.87 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.3M | $618.7M |
| 总债务越低越好 | $455.7M | $9.0B |
| 股东权益账面价值 | $726.2M | $9.7B |
| 总资产 | $1.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.63× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AINRPRX
| Q4 25 | $112.3M | $618.7M | ||
| Q3 25 | $108.3M | $938.9M | ||
| Q2 25 | $106.7M | $631.9M | ||
| Q1 25 | $119.4M | $1.1B | ||
| Q4 24 | $115.3M | $929.0M | ||
| Q3 24 | $127.2M | $950.1M | ||
| Q2 24 | $116.4M | $1.8B | ||
| Q1 24 | $125.4M | $843.0M |
总债务AINRPRX
| Q4 25 | $455.7M | $9.0B | ||
| Q3 25 | $480.6M | $8.9B | ||
| Q2 25 | $444.7M | $8.0B | ||
| Q1 25 | $416.4M | $7.6B | ||
| Q4 24 | $318.5M | $7.6B | ||
| Q3 24 | $362.2M | $7.6B | ||
| Q2 24 | $377.1M | $7.6B | ||
| Q1 24 | $439.1M | $6.1B |
股东权益AINRPRX
| Q4 25 | $726.2M | $9.7B | ||
| Q3 25 | $739.3M | $9.6B | ||
| Q2 25 | $888.6M | $9.5B | ||
| Q1 25 | $900.0M | $9.8B | ||
| Q4 24 | $943.5M | $10.3B | ||
| Q3 24 | $991.0M | $10.3B | ||
| Q2 24 | $967.5M | $9.8B | ||
| Q1 24 | $967.5M | $9.9B |
总资产AINRPRX
| Q4 25 | $1.7B | $19.6B | ||
| Q3 25 | $1.7B | $19.3B | ||
| Q2 25 | $1.7B | $18.3B | ||
| Q1 25 | $1.7B | $17.6B | ||
| Q4 24 | $1.6B | $18.2B | ||
| Q3 24 | $1.8B | $18.0B | ||
| Q2 24 | $1.8B | $17.7B | ||
| Q1 24 | $1.8B | $16.1B |
负债/权益比AINRPRX
| Q4 25 | 0.63× | 0.92× | ||
| Q3 25 | 0.65× | 0.93× | ||
| Q2 25 | 0.50× | 0.84× | ||
| Q1 25 | 0.46× | 0.78× | ||
| Q4 24 | 0.34× | 0.74× | ||
| Q3 24 | 0.37× | 0.74× | ||
| Q2 24 | 0.39× | 0.78× | ||
| Q1 24 | 0.45× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $51.4M | — |
| 自由现金流率自由现金流/营收 | 16.0% | — |
| 资本支出强度资本支出/营收 | 6.9% | — |
| 现金转化率经营现金流/净利润 | 5.31× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $82.6M | — |
8季度趋势，按日历期对齐
经营现金流AINRPRX
| Q4 25 | $73.7M | $827.1M | ||
| Q3 25 | $43.9M | $702.6M | ||
| Q2 25 | $32.7M | $364.0M | ||
| Q1 25 | $2.1M | $596.1M | ||
| Q4 24 | $78.5M | $742.5M | ||
| Q3 24 | $47.0M | $703.6M | ||
| Q2 24 | $83.4M | $658.2M | ||
| Q1 24 | $9.6M | $664.6M |
自由现金流AINRPRX
| Q4 25 | $51.4M | — | ||
| Q3 25 | $25.9M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $-13.5M | — | ||
| Q4 24 | $60.2M | — | ||
| Q3 24 | $31.6M | — | ||
| Q2 24 | $63.6M | — | ||
| Q1 24 | $-17.3M | — |
自由现金流率AINRPRX
| Q4 25 | 16.0% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | -4.7% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | 19.2% | — | ||
| Q1 24 | -5.5% | — |
资本支出强度AINRPRX
| Q4 25 | 6.9% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 8.6% | — |
现金转化率AINRPRX
| Q4 25 | 5.31× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 3.56× | 12.06× | ||
| Q1 25 | 0.12× | 2.50× | ||
| Q4 24 | 4.44× | 3.57× | ||
| Q3 24 | 2.61× | 1.29× | ||
| Q2 24 | 3.39× | 6.45× | ||
| Q1 24 | 0.35× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
